How to target Glutamine as a Cancer Source with Dr. Thomas Seyfried, MD

Video Overview & Chapters

00:07 Glutamine is essential for immune system and gut health.

• Glutamine, which can be synthesized from glucose, is the most abundant amino acid in our bloodstream.
• Glutamine plays a crucial role in the urea cycle and is considered important for overall immune system and gut function.

00:52 Glutamine can be targeted as a cancer source

• Glutamine is essential for certain physiological systems, but there is no food that can deprive you of it
• Water-only fasting with exercise can lower blood glutamine levels significantly, which may impact tumor cells

01:40 Targeting Glutamine to slow cancer cells progression.

• Pulsing tumor cells with glutamine to degrade them gradually.
• Long-term water fasting may help some people in cancer remission.

02:24 Body can use tumor cells as food during fasting

• Body turns on tumor cells as a food source during fasting.
• Tumor cells are inefficient consumers of energy.

03:04 Putting the body under restricted conditions can trigger the surveillance system to target and destroy tumor cells.

• Restrictive conditions lead to tumor cell destruction and redistribution of fuel.
• Stress, whether emotional or physical, can impact blood sugar levels and corticosteroids.

03:49 Targeting glutamine as a cancer source

• Stress management is an important therapeutic strategy for cancer treatment, alongside dietary and drug-based methods targeting glutamine.
• Emotional stress reduction is crucial for the body's overall healing ability, in addition to fuel deprivation caused by diet and drugs targeting glutamine.

04:36 Targeting glucose is crucial for using a powerful cancer therapy drug.

• Patients were given high dosages of the drug without targeting glucose, resulting in misuse and negative outcomes.
• The drug should be a part of cancer therapy cocktails, but bureaucratic challenges hinder patient access.

05:13 Challenges in accessing potentially beneficial drugs for cancer patients

• State and Federal paperwork hurdles can hinder access to drugs even for compassionate use
• Financial incentives play a role in limiting availability of off-patent drugs with therapeutic potential